The University of New South Wales

Subject Area Index

See LEGEND for key to shading and symbols.


Subject Area - PHAR  Term - Semester 2 2017

PHAR2011 PHAR3101 PHAR3202 PHAR3306 PHAR9104 PHAR9111
PHAR9115 PHAR9117 PHAR9120 PHAR9121 PHAR9124

Data is correct as at Thu Sep 21 12:01:02 AEST 2017


Comp Sect Class Type Status Enr/Cap % Full Times (weeks, Location) - default 1hour 
PHAR2011   Introductory Pharmacology and
LABM10A 3755RelOpen76/78 97%   Mon 10-13 (w1-2,4,6,8,12, Wurth 115)
LABM10B 3756RelOpen76/78 97%   Mon 10-13 (w1, Wurth 115); Mon 10-13 (w3,5,7,9,11, Wurth 115)
LABM14A 3757RelOpen70/78 90%   Mon 14-17 (w1-2,4,6,8,12, Wurth 115)
LABM14B 3758RelTent0/75 0%   Mon 14-17 (w1, Wurth 115); Mon 14-17 (w3,5,7,9,11, Wurth 115)
LECA 3754RelOpen222/234 95%   Tue 13 (w1-9,10-12, Rex Vowels); Wed 14 (w1-9,10-12, Clancy Aud)
TUTT17A 3763EnrOpen39/45 87%   Tue 17 (w2-9,10-13, Mat 105)
TUTT17B 3764EnrTent0/0 N/A   Tue 17 (w2-9,10-13, Mat 104)
TUTW15A 3761EnrOpen47/50 94%   Wed 15 (w2-9,10-13, Mat 309)
TUTW15B 3762EnrFull50/50 100%   Wed 15 (w2-9,10-13, Mat 105)
TUTW16A 3759EnrOpen44/45 98%   Wed 16 (w2-9,10-13, Mat 105)
TUTW16B 3760EnrOpen42/45 93%   Wed 16 (w2-9,10-13, Mat 312)
PHAR3101   Drug Discovery, Design & Devel
LABT14A 4900EnrOpen57/60 95%   Tue 14-17 (Wurth 120)
LECA 4899RelOpen57/60 95%   Wed 10 (WurthLG02); Wed 14 (MacauleyTh)
TUTW15A 4902RelFull30/30 100%   Wed 15 (Webst 302)
TUTW16A 4901RelOpen27/30 90%   Wed 16 (Webst 302)
PHAR3202   Neuropharmacology
LABF09A 6217EnrOpen37/40 93%   Fri 09-12 (w2-9,10-13, Wurth 120)
LABF13A 6216EnrOpen32/40 80%   Fri 13-16 (w2-9,10-13, Wurth 120)
LECA 6215RelOpen69/78 88%   Mon 17 (w1-9,11-13, WurthLG03); Wed 15 (Law Th G02)
TUTT09A 6218RelOpen20/26 77%   Tue 09 (w1-9,10-12, AGSM LG06)
TUTT10A 6219RelOpen25/26 96%   Tue 10 (w1-9,10-12, AGSM LG06)
TUTT11A 6220RelOpen24/26 92%   Tue 11 (w1-9,10-12, AGSM LG06)
PHAR3306   Pharmacology for Optometry
LABH15A 6222EnrOpen93/96 97%   Thu 15-18 (w3,5,7-9,11,13, WurthG06)
LECA 6221RelOpen93/96 97%   Mon 14 (w1-9,11-13, AinswthG02); Wed 16-18 (AinswthG02)
TUTH15B 6223RelFull33/32 > 100%   Thu 15 (w4,6,10,12, Mat 106)
TUTH16A 6224RelFull32/32 100%   Thu 16 (w4,6,10,12, Mat 106)
TUTH17A 6225RelOpen28/32 88%   Thu 17 (w4,6,10,12, Mat 106)
PHAR9104   Legal/Regulatory Devlp of Med
DSTA 9911EnrOpen14/30 47%  
PHAR9111   Pharmaceutics
DSTA 9912EnrOpen10/30 33%  
PHAR9115   Advanced HTA
DSTA 9913EnrClosed0/5 0%  
PHAR9117   Cancer Therapeutics
DSTA 9915EnrClosed0/30 0%  
PHAR9120   Clinical Trials
DSTA 9917EnrOpen13/30 43%  
PHAR9121   Pharmacovigilance
DSTA 9918EnrOpen26/45 58%  
PHAR9124   Internship
DSTA 9919EnrFull*1/1 100%  
^ top ^
LEGEND
* This class requires consent. Students cannot self-enrol.
# Timetable clash allowed.
/odd  Runs in odd weeks only.     /even  Runs in even weeks only.
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity.
      Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes.
[  ] Class capacity where different from effective capacity.
  
Shaded cells:  LEC Activity different from previous
Stop Status is Stop Further Enrolment, Tentative, Closed or Cancelled
100%   Class is full (> 100% means capacity is exceeded)
80%   Class is nearly full (80% or more)
50%   Class is half full
0%   Class is less than half full